(Alliance News) - GSK PLC on Friday said European regulators have recommended broadening the indication for its Arexvy vaccine to all adults aged 18 and older. Read More
(Alliance News) - Stock prices in London opened higher on Friday, after UK data revealed a widened trade deficit and the economy shrinking in October. Read More
(Alliance News) - SolGold PLC on Friday said it has received an all-cash takeover proposal that the board is minded to accept and that already has the support of shareholders with a 40% stake. Read More
(Alliance News) - 1Spatial PLC on Friday said it has agreed in principle a proposed GBP87.1 million offer from VertiGIS Ltd, a portfolio company of London-based private equity firm Battery Ventures. Read More
(Alliance News) - The UK's trade deficit increased sharply in the three months to October, the Office for National Statistics reported Friday. Read More
(Alliance News) - Stocks were called to open higher in London on Friday, as the Office for National Statistics reported that the UK economy unexpectedly shrank in October. Read More
Baltic Classifieds Group PLC - online classified ads portal provider in Lithuania, Estonia and Latvia - Non-Executive Director Ed Williams buys 211,095 at average 189.01 pence, worth GBP398,988, on Thursday. Williams now has 3.3 million shares, a 0.7% stake. Read More
(Alliance News) - The UK economy shrank in October and in the three months leading up to October, the Office for National Statistics reported on Friday. Read More
Volex PLC - Hampshire, England-based maker of power and data transmission products - Dave Webster, the newly installed non-executive chair of Volex, buys 113,096 shares at average 408.34 pence, worth GBP461,816, on Monday, Tuesday and Wednesday. They are Webster's first shares. He was brought in last month amid a leadership shake-up that saw Nat Rothschild move to chief executive from executive chair. Read More
(Alliance News) - Stocks in London are set to open higher on Friday, ahead of UK gross domestic product, trade balance and industrial production data. Read More
(Alliance News) - Welcome to the Alliance News UK service (ISSN 2515-9453), consisting of the Alliance News UK Professional and its family of financial newswires serving investors and their professional advisers. Read More
GSK PLC - London-based pharmaceuticals firm - US Food & Drug Administration approves a supplemental new drug application for gepotidacin as an oral option for adult and paediatric patients from 12 years of age for the treatment of uncomplicated urogenital gonorrhoea. This follows the US FDA approval of gepotidacin earlier this year as an oral treatment for female adult and paediatric patients 12 years of age and older with uncomplicated urinary tract infection. The application was based on positive results from the Eagle-1 phase III trial which demonstrated that gepotidacin was non-inferior to standard of care combination treatment for gonorrhoea. The trial also supported the safety and tolerability profile of gepotidacin, with no serious drug related adverse events observed in either the gepotidacin or the comparator arm. The most common reported adverse reactions were mild to moderate gastrointestinal events. Read More
(Alliance News) - The FTSE 100 forged ahead on Thursday as a less 'hawkish' than feared rate cut by the US Federal Reserve and a brighter US economic outlook spurred stocks, despite some fresh AI worry. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - CVS Group PLC said it will begin trading on London's Main Market from next month. Read More